Tissue-Based Testing News on immunohistochemistry and other tissue-based testing methods. Agilent, Akoya to Commercialize Workflow Tools for Tissue Biomarker Analysis The end-to-end workflow products are intended for biopharmaceutical companies developing companion diagnostics for precision cancer therapeutics. Functional Precision Medicine Firm Kiyatec Raises $18M in Series C Funding Round The Clemson University spinout is developing live tissue-based models of cancer cells for use in predicting patients' individual drug responses. Cofactor Genomics RNA-seq Assay Outperforms PD-L1 IHC to Predict Immunotherapy Responders Premium The firm is aiming to commercialize its OncoPrism assay in 2023 as a laboratory-developed test to identify head and neck cancer patients eligible for checkpoint inhibitors. Oncgnostics Epigenetic Cervical Cancer Test Wins Chinese Regulatory Approval The GynTect assay detects oncogenic DNA methylation markers from cervical smear samples following abnormal cancer-screen findings. Bio-Techne Nabs CE Mark for HPV Head and Neck Cancer Test, Completes Namocell Acquisition The RNAscope ISH Probe High Risk HPV test detects E6/E7 mRNA and is intended to help inform treatment selection in oropharyngeal squamous cell carcinoma patients. Jun 3, 2022 Swiss Immunohistochemistry Firm Lunaphore Shifts Focus to High-Plex Spatial Proteomics Premium Jun 3, 2022 Foundation Medicine to Provide Comprehensive Genomic Profiling Tests in Lung Cancer Screening Trial Jun 1, 2022 Max Planck Team Develops Workflow Combining Single-Cell Imaging With Deep Proteomic Profiling Premium May 11, 2022 Thermo Fisher Scientific Invests in Spatial Proteomics Firm Ionpath Mar 22, 2022 Precision Medicine Firm PreludeDx Closes $20M Funding Round Mar 8, 2022 Guardant Health Receives Medicare Coverage for Tissue-Based Cancer Test Sep 9, 2021 RareCyte Secures $24M to Advance Spatial Biology Platform, Expand Globally Jun 22, 2021 Guardant Health Targets Emerging Treatment Response Market With New ctDNA Product Premium Mar 9, 2021 Foundation Medicine, InformedDNA Partner to Expand Genetic Counseling for Cancer Patients Mar 2, 2021 PreludeDx DCIS Breast Cancer Test Helps Determine Radiation Therapy Benefits, Reduce Overtreatment Premium Jan 19, 2021 Blood, Urine Biomarker Study Leads to Linked Loci, Disease-Related Risk Scores Dec 10, 2020 Spatial Analysis Startup Resolve Biosciences Launches With $24M Series A Financing Round Nov 18, 2020 Indivumed, Ultivue Sign Deal to Integrate Cancer Tissue Analysis Technologies Sep 22, 2020 Promega to Develop MSI Assay as CDx for Incyte Endometrial Cancer Drug Aug 21, 2020 Owkin Machine Learning Infers RNA Expression From Tissue Images in New Study Premium Jul 22, 2020 Ultivue, OracleBio Collaborate on Tissue Biomarker Analysis Workflow Jul 17, 2020 RareCyte Targets Spatial Biology Market with New Orion Instrument Premium May 26, 2020 Bio-Techne, Leica Biosystems Receive CE Mark for Pathology Detection Kit, Platform May 15, 2020 CareDx Hybrid Capture Tech for HLA Testing Receives CE Marking Mar 11, 2020 DermTech Q4 Revenues Soar 152 Percent Load More Breaking News Cancer Prognoses Informed by Module-Based Approach, Study Finds People in the News at Illumina, Centogene, BioSkryb New Products Posted to GenomeWeb: Bio-Rad, BD, Analytik Jena, BioMérieux Genetic Technologies to Raise A$5M in Direct Stock Offering In Brief This Week: SD Biosensors, Meridian, Oncocyte, Opko Health, GeneDx, More The Scan Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency. Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis. Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven. White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.